Owell Naturals Draw Salve with Camphor 2.0 oz.

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Owell Naturals Draw Salve with Camphor 2.0 oz.
Generic name: CAMPHOR
Manufacturer: Owell Naturals Brand LLC
Product type: HUMAN OTC DRUG
SPL set ID: 1859acdc-d8d4-52a2-e063-6294a90aff74
SPL ID: 3ea0ab4d-0f01-2e85-e063-6394a90aa107
Version: 5
Effective date: 2025-09-12
Source export date: 2026-10-27
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/a73bb3b6a943796a18cd4bcd0917240b579be4636d00e6e39481bafbd8093f69/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:36:17

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Owell Naturals Draw Salve with Camphor 2.0 oz.	openfda.brand_name
generic name		CAMPHOR	openfda.generic_name
manufacturer name		Owell Naturals Brand LLC	openfda.manufacturer_name
ndc	package	83570-540-01	openfda.package_ndc
ndc	product	83570-540	openfda.product_ndc
ndc11	package	83570054001	derived:openfda.package_ndc
spl id		3ea0ab4d-0f01-2e85-e063-6394a90aa107	id
spl set id		1859acdc-d8d4-52a2-e063-6294a90aff74	set_id
unii		N20HL7Q941	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Allergy Alert: If prone to allergic reaction from aspirin or salicylate, consult your doctor before using. Do Not Use: on wounds or damaged skin with a heating pad on a child under 12 years of age with arthritis-like conditions Stop use and ask a doctor if condition worsens or symptoms persist for more than 7 days symptoms clear up and occur again within a few days

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.